The 'go to' European specialist pharma company
In March 2017, Norgine entered into an agreement with Noventure S.L., under which Norgine will distribute GELSECTAN® in Spain, Portugal and Andorra.
Norgine entered an agreement with Apharm s.r.l. to distribute ZIVEREL® in Spain, Australia and New Zealand.
Norgine divests its Southern African operations and product rights to Aspen.
Prof. Emil Starkenstein the ‘Father of Pharmacology’ was an early academic collaborator with Norgine
Norgine B.V., Hogehilweg 7. 1101 CA Amsterdam Zuid-Oost. The Netherlands. Registered number 30127007. Copyright Norgine 2014
All product names mentioned in this website are trademarks owned by or licensed to the Norgine group of companies, unless otherwise noted